222 related articles for article (PubMed ID: 33064576)
1. Triclocarban, Triclosan, Bromochlorophene, Chlorophene, and Climbazole Effects on Nuclear Receptors: An
Kenda M; Karas Kuželički N; Iida M; Kojima H; Sollner Dolenc M
Environ Health Perspect; 2020 Oct; 128(10):107005. PubMed ID: 33064576
[TBL] [Abstract][Full Text] [Related]
2. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
[TBL] [Abstract][Full Text] [Related]
3. Effects of tyrosine kinase inhibitors on androgen, estrogen α, glucocorticoid and thyroid receptors.
Kenda M; Avsec D; Zore T; Kogovšek E; Pečar Fonović U; Kos J; Bozovičar K; Bratkovič T; Karas Kuželički N; Žegura B; Filipič M; Sollner Dolenc M
Toxicol Appl Pharmacol; 2022 Jan; 434():115818. PubMed ID: 34890638
[TBL] [Abstract][Full Text] [Related]
4. Effects of central nervous system drugs on androgen, estrogen α, glucocorticoid, and thyroid receptors.
Kenda M; Zore T; Sollner Dolenc M
Chem Biol Interact; 2022 Aug; 363():110030. PubMed ID: 35760085
[TBL] [Abstract][Full Text] [Related]
5. Endocrine Activity of AVB, 2MR, BHA, and Their Mixtures.
Klopcic I; Dolenc MS
Toxicol Sci; 2017 Mar; 156(1):240-251. PubMed ID: 28115641
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of endocrine activities of ellagic acid and urolithins using reporter gene assays.
Gramec Skledar D; Tomašič T; Sollner Dolenc M; Peterlin Mašič L; Zega A
Chemosphere; 2019 Apr; 220():706-713. PubMed ID: 30611068
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M
Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421
[TBL] [Abstract][Full Text] [Related]
8. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
[TBL] [Abstract][Full Text] [Related]
9. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
Wilson VS; Bobseine K; Lambright CR; Gray LE
Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
[TBL] [Abstract][Full Text] [Related]
10. Investigation of In Vitro Endocrine Activities of
Mallia V; Ivanova L; Eriksen GS; Harper E; Connolly L; Uhlig S
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260386
[TBL] [Abstract][Full Text] [Related]
11. An in vitro investigation on the cytotoxic and nuclear receptor transcriptional activity of the mycotoxins fumonisin B1 and beauvericin.
Fernández-Blanco C; Frizzell C; Shannon M; Ruiz MJ; Connolly L
Toxicol Lett; 2016 Aug; 257():1-10. PubMed ID: 27234500
[TBL] [Abstract][Full Text] [Related]
12. The in vitro estrogenic activities of triclosan and triclocarban.
Huang H; Du G; Zhang W; Hu J; Wu D; Song L; Xia Y; Wang X
J Appl Toxicol; 2014 Sep; 34(9):1060-7. PubMed ID: 24740835
[TBL] [Abstract][Full Text] [Related]
13. Cyclic depsipeptide mycotoxin exposure may cause human endocrine disruption: Evidence from OECD in vitro stably transfected transcriptional activation assays.
Park Y; Lee HS
Reprod Toxicol; 2021 Mar; 100():52-59. PubMed ID: 33346041
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of tetrabromobisphenol A effects on human glucocorticoid and androgen receptors: A comparison of results from human- with yeast-based in vitro assays.
Beck KR; Sommer TJ; Schuster D; Odermatt A
Toxicology; 2016 Aug; 370():70-77. PubMed ID: 27693315
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in silico approach to study the hormonal activities of the alternative plasticizer tri-(2-ethylhexyl) trimellitate TEHTM and its metabolites.
Dahbi L; Farce A; Kambia N; Séverin I; Dine T; Moreau E; Sautou V; Chagnon MC
Arch Toxicol; 2022 Mar; 96(3):899-918. PubMed ID: 35089383
[TBL] [Abstract][Full Text] [Related]
16. Screening of bisphenol A, triclosan and paraben analogues as modulators of the glucocorticoid and androgen receptor activities.
Kolšek K; Gobec M; Mlinarič Raščan I; Sollner Dolenc M
Toxicol In Vitro; 2015 Feb; 29(1):8-15. PubMed ID: 25192815
[TBL] [Abstract][Full Text] [Related]
17. Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events.
Svärd J; Blanco F; Nevin D; Fayne D; Mulcahy F; Hennessy M; Spiers JP
Br J Pharmacol; 2014 Jan; 171(2):480-97. PubMed ID: 24372550
[TBL] [Abstract][Full Text] [Related]
18. A comparison of endocrine disruption potential of nonylphenol ethoxylate, vanillin ethoxylate, 4-n-nonylphenol and vanillin in vitro.
Ji X; Li N; Yuan S; Zhou X; Ding F; Rao K; Ma M; Wang Z
Ecotoxicol Environ Saf; 2019 Jul; 175():208-214. PubMed ID: 30901638
[TBL] [Abstract][Full Text] [Related]
19. Theoretical study on endocrine disrupting effects of polychlorinated dibenzo-p-dioxins using molecular docking simulation.
Akinola LK; Uzairu A; Shallangwa GA; Abechi SE
J Appl Toxicol; 2021 Feb; 41(2):233-246. PubMed ID: 32656810
[TBL] [Abstract][Full Text] [Related]
20. The urinary metabolites of DINCH
Engel A; Buhrke T; Kasper S; Behr AC; Braeuning A; Jessel S; Seidel A; Völkel W; Lampen A
Toxicol Lett; 2018 May; 287():83-91. PubMed ID: 29421333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
